Dosage forms containing fluticasone propionate for the treatment of inflammatory conditions of the esophagus

1. A liquid pharmaceutical composition comprising fluticasone propionate in combination with 2.0 wt % of sodium alginate as viscosity enhancer and other non-active ingredients, said non-active ingredients comprising:

(i) 0.075 wt % of sucralose as edulcorant;

(ii) 0.1 wt % of carbomer as suspending agent;

(iii) 0.002 wt % of polysorbate 80 as wetting agent surfactant; and

(iv) about 0.2 wt % of a mixture of methylparaben and propylparaben as preservative; and

(v) sodium hydroxide,

wherein the liquid pharmaceutical composition is formulated for oral administration and has a pH between 6.5 and 7.5.